My research has focused on rare, monogenetic skin diseases such as Epidermolysis Bullosa (EB) and Gorlin Syndrome (Basal Cell Nevus Syndrome). With my PhD training in basic science, post-doctoral fellowship in clinical research, and residency in dermatology, I am committed to improving the lives of EB patients, to correct their underlying genetic disease and to offer new treatments for their skin and esophageal wounds. I was the PI of the investigator-initiated, Phase 1/2A clinical trial of autologous gene-therapy skin grafts for RDEB (Pz-cel, EB-101, previously called LEAES).
Partial Data by Infogroup (c) 2025. All rights reserved.
